Sustainability Report

Overview

The report covers iX Biopharma's sustainability performance across all entities for FY2024, from July 2023 to June 2024. It reports total revenue of 5,959 $'000, 59 employees, energy consumption of 1,059,707 kWh and Scope 2 emissions of 949 t CO2-e. The company reports 20% female representation on its Board and zero work-related fatalities. It also describes a materiality assessment, full product testing and no cases of product-safety non-compliance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 July 2023 – 30 June 2024
Publication date: 30 September 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services